Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPhase I study of combination therapy with weekly paclitaxel and cyclophosphamide for advanced or recurrent breast cancer
Cancer Chemotherapy and Pharmacology, 09/23/09
Masuda N et al. – Although anthracycline is a key agent in breast cancer treatment, its use is associated with the risk of cardiotoxicity. Recently, the value of combination therapy with docetaxel and cyclophosphamide was reported. Safety was well tolerated throughout the four courses at level 2, and this dosage level was therefore regarded as the RD.
Related Articles
Mammographic Screening and Risk Factors for Breast Cancer
American Journal of Epidemiology, 10/30/09
Relevance Score: 82%
Energy Intake and Risk of Postmenopausal Breast Cancer: An Expanded Analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort
Cancer Epidemiology, Biomarkers & Prevention, 10/23/09
Relevance Score: 82%
Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging
The American Journal of Surgery, 10/07/09
Relevance Score: 82%
The predictive value of incidental PET/CT findings suspicious for breast cancer in women with non-breast malignancies
The American Journal of Surgery, 10/06/09
Relevance Score: 82%
A case–control study of reproductive factors associated with subtypes of breast cancer in Northeast China
Medical Oncology, 10/01/09
Relevance Score: 82%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Triweekly Oxaliplatin Plus Oral Capecitabine as First-Line Chemotherapy in Elderly Patients With Advanced Gastric Cancer
American Journal of Clinical Oncology, 12/07/09
Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)
Annals of Oncology, 12/07/09
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study
Annals of Oncology, 12/07/09
Sponsor
Article Search
Sponsor